Strs Ohio Sells 9,963 Shares of Astera Labs, Inc. $ALAB

Strs Ohio cut its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 76.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,012 shares of the company’s stock after selling 9,963 shares during the quarter. Strs Ohio’s holdings in Astera Labs were worth $590,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of ALAB. Grove Bank & Trust purchased a new stake in shares of Astera Labs in the third quarter valued at $68,000. Bernard Wealth Management Corp. bought a new position in Astera Labs during the 2nd quarter valued at about $36,000. Clearstead Trust LLC lifted its stake in Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after purchasing an additional 461 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in Astera Labs by 68.6% in the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after purchasing an additional 194 shares during the last quarter. Finally, Manchester Capital Management LLC lifted its stake in Astera Labs by 141.5% in the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after purchasing an additional 283 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Trading Down 6.1%

ALAB opened at $150.62 on Friday. The firm has a market cap of $25.44 billion, a price-to-earnings ratio of 135.69, a PEG ratio of 2.19 and a beta of 1.50. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a fifty day moving average price of $163.98 and a 200-day moving average price of $171.15.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 90,459 shares of the company’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief operating officer directly owned 1,599,750 shares in the company, valued at approximately $231,467,827.50. The trade was a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 576,936 shares of company stock worth $87,409,540. 12.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

ALAB has been the topic of several recent analyst reports. Northland Securities increased their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a research report on Wednesday, January 21st. Raymond James Financial initiated coverage on Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating on the stock. Royal Bank Of Canada began coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target on the stock. Finally, Barclays set a $165.00 price objective on shares of Astera Labs in a research report on Thursday, January 15th. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $190.63.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.